CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Portable sleep monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03473548
NCT03473548N/ACompleted

Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients

Washington University School of Medicine·interventional·Posted Mar 22, 2018·Updated Feb 7, 2024

In Brief

A clinical study evaluating Portable sleep monitor and In-laboratory Polysomnography for Sleep Apnea, Obstructive. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of the study is: 1) To assess the feasibility of unmonitored polysomnography and 2) to compare apnea hypopnea index (AHI), average SPO2, and SPO2 nadir between unmonitored polysomnography and in-laboratory polysomnography in pediatric patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 22, 2018
Enrollment StartDec 28, 2017
Primary CompletionOct 14, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.3 years ago

Interventions

Portable sleep monitordevice

Type III at home portable monitor obtaining greater than or equal to 6 hours of data adequate for polysomnography analysis

In-laboratory Polysomnographyother

Polysomnography testing will determine the sleep stages, apnea hypopnea index (AHI), blood saturation oxygen nadir (SPO2 nadir), and average blood oxygen saturation. A McGill Oximetry Score will also be calculated for the in-laboratory PSG.